Rab3A deletion selectively reduces spontaneous neurotransmitter release at the mouse neuromuscular synapse

Brain Research

Volumn 1089, Issue 1, 2006, Pages 126-134

  Sons, Michèle S ^a   Plomp, Jaap J ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Exocytosis; Neuromuscular junction; Neurotransmitter release; Rab3a; Synapse

Indexed keywords

ACETYLCHOLINE; ALPHA LATROTOXIN; HYPERTONIC SOLUTION; ISOPROTEIN; RAB PROTEIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIAPHRAGM MUSCLE; EVOKED RESPONSE; GENE DELETION; GENE MUTATION; MICROELECTRODE; MOUSE; NERVE POTENTIAL; NERVE STIMULATION; NEUROMUSCULAR SYNAPSE; NEUROTRANSMITTER RELEASE; NONHUMAN; PARALYSIS; PRIORITY JOURNAL; SOLEUS MUSCLE; WILD TYPE;

ACETYLCHOLINE; ACTION POTENTIALS; ANIMALS; HYPERTONIC SOLUTIONS; MICE; MICE, KNOCKOUT; MOTOR NEURONS; NEUROMUSCULAR JUNCTION; NEUROTRANSMITTER AGENTS; PRESYNAPTIC TERMINALS; PROTEIN ISOFORMS; RAB3A GTP-BINDING PROTEIN; SPIDER VENOMS; SYNAPTIC TRANSMISSION; SYNAPTIC VESICLES;

EID: 33646793328     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2006.03.055     Document Type: Article

References (42)

1. Bewick G.S. Maintenance of transmitter release from neuromuscular junctions with different patterns of usage "in vivo". J. Neurocytol. 32 (2003) 473-487
2. Castillo P.E., Schoch S., Schmitz F., Sudhof T.C., and Malenka R.C. RIM1alpha is required for presynaptic long-term potentiation. Nature 415 (2002) 327-330
3. D'Adamo P., Wolfer D.P., Kopp C., Tobler I., Toniolo D., and Lipp H.P. Mice deficient for the synaptic vesicle protein Rab3a show impaired spatial reversal learning and increased explorative activity but none of the behavioral changes shown by mice deficient for the Rab3a regulator Gdi1. Eur. J. Neurosci. 19 (2004) 1895-1905
4. Darchen F., and Goud B. Multiple aspects of Rab protein action in the secretory pathway: focus on Rab3 and Rab6. Biochimie 82 (2000) 375-384
5. Fischer von Mollard G., Sudhof T.C., and Jahn R. A small GTP-binding protein dissociates from synaptic vesicles during exocytosis. Nature 349 (1991) 79-81
6. Fischer von Mollard G., Stahl B., Khokhlatchev A., Sudhof T.C., and Jahn R. Rab3C is a synaptic vesicle protein that dissociates from synaptic vesicles after stimulation of exocytosis. J. Biol. Chem. 269 (1994) 10971-10974
7. Geppert M., Bolshakov V.Y., Siegelbaum S.A., Takei K., De Camilli P., Hammer R.E., and Sudhof T.C. The role of Rab3A in neurotransmitter release. Nature 369 (1994) 493-497
8. Geppert M., Goda Y., Stevens C.F., and Sudhof T.C. The small GTP-binding protein Rab3A regulates a late step in synaptic vesicle fusion. Nature 387 (1997) 810-814
9. Giovedi S., Vaccaro P., Valtorta F., Darchen F., Greengard P., Cesareni G., and Benfenati F. Synapsin is a novel Rab3 effector protein on small synaptic vesicles: I. Identification and characterization of the synapsin I-Rab3 interactions in vitro and in intact nerve terminals. J. Biol. Chem. 279 (2004) 43760-43768
10. Glavinovic M.I. Presynaptic action of curare. J. Physiol. 290 (1979) 499-506
11. Hirsh J.K., Searl T.J., and Silinsky E.M. Regulation by Rab3A of an endogenous modulator of neurotransmitter release at mouse motor nerve endings. J. Physiol. 545 (2002) 337-343
12. Hong S.J., and Chang C.C. Use of geographutoxin II (mu-conotoxin) for the study of neuromuscular transmission in mouse. Br. J. Pharmacol. 97 (1989) 934-940
13. Kaja S., van de Ven R.C., Broos L.A., Frants R.R., Ferrari M.D., Van Den Maagdenberg A.M., and Plomp J.J. Increased transmitter release at neuromuscular synapses of a novel cacna1a S218L knock-in mouse model for familial hemiplegic migraine. Soc. Neurosci. (2004) 593.4
14. Kaja S., van de Ven R.C., Broos L.A., Veldman H., Van Dijk J.G., Verschuuren J.J., Frants R.R., Ferrari M.D., Van Den Maagdenberg A.M., and Plomp J.J. Gene dosage-dependent transmitter release changes at neuromuscular synapses of CACNA1A R192Q knockin mice are non-progressive and do not lead to morphological changes or muscle weakness. Neuroscience 135 (2005) 81-95
15. Kapfhamer D., Valladares O., Sun Y., Nolan P.M., Rux J.J., Arnold S.E., Veasey S.C., and Bucan M. Mutations in Rab3a alter circadian period and homeostatic response to sleep loss in the mouse. Nat. Genet. 32 (2002) 290-295
16. Kim Y.I., and Neher E. IgG from patients with Lambert-Eaton syndrome blocks voltage-dependent calcium channels. Science 239 (1988) 405-408
17. Leenders A.G., Lopes da Silva F.H., Ghijsen W.E., and Verhage M. Rab3a is involved in transport of synaptic vesicles to the active zone in mouse brain nerve terminals. Mol. Biol. Cell 12 (2001) 3095-3102
18. Lin R.C., and Scheller R.H. Mechanisms of synaptic vesicle exocytosis. Annu. Rev. Cell Dev. Biol. 16 (2000) 19-49
19. Lou X., Scheuss V., and Schneggenburger R. Allosteric modulation of the presynaptic Ca2+ sensor for vesicle fusion. Nature 435 (2005) 497-501
20. Magleby K.L., and Stevens C.F. A quantitative description of end-plate currents. J. Physiol. 223 (1972) 173-197
21. Maselli R.A., Kong D.Z., Bowe C.M., McDonald C.M., Ellis W.G., Agius M.A., Gomez C.M., Richman D.P., and Wollmann R.L. Presynaptic congenital myasthenic syndrome due to quantal release deficiency. Neurology 57 (2001) 279-289
22. Maselli R.A., Books W., and Dunne V. Effect of inherited abnormalities of calcium regulation on human neuromuscular transmission. Ann. N.Y. Acad. Sci. 998 (2003) 18-28
23. Maselli R.A., Wan J., Dunne V., Graves M., Baloh R.W., Wollmann R.L., and Jen J. Presynaptic failure of neuromuscular transmission and synaptic remodeling in EA2. Neurology 61 (2003) 1743-1748
24. Mizoguchi A., Arakawa M., Masutani M., Tamekane A., Yamaguchi H., Minami N., Takai Y., and Ide C. Localization of smg p25A/rab3A p25, a small GTP-binding protein, at the active zone of the rat neuromuscular junction. Biochem. Biophys. Res. Commun. 186 (1992) 1345-1352
25. Plomp J.J., van Kempen G.T., and Molenaar P.C. Adaptation of quantal content to decreased postsynaptic sensitivity at single endplates in alpha-bungarotoxin-treated rats. J. Physiol. 458 (1992) 487-499
26. Plomp J.J., van Kempen G.T., and Molenaar P.C. The upregulation of acetylcholine release at endplates of alpha-bungarotoxin-treated rats: its dependency on calcium. J. Physiol. 478 (1994) 125-136
27. Plomp J.J., Vergouwe M.N., Van Den Maagdenberg A.M., Ferrari M.D., Frants R.R., and Molenaar P.C. Abnormal transmitter release at neuromuscular junctions of mice carrying the tottering alpha(1A) Ca(2+) channel mutation. Brain 123 (2000) 463-471
28. Prakash Y.S., Miller S.M., Huang M., and Sieck G.C. Morphology of diaphragm neuromuscular junctions on different fibre types. J. Neurocytol. 25 (1996) 88-100
29. Sara Y., Virmani T., Deak F., Liu X., and Kavalali E.T. An isolated pool of vesicles recycles at rest and drives spontaneous neurotransmission. Neuron 45 (2005) 563-573
30. Schluter O.M., Schmitz F., Jahn R., Rosenmund C., and Sudhof T.C. A complete genetic analysis of neuronal Rab3 function. J. Neurosci. 24 (2004) 6629-6637
31. Shirataki H., Kaibuchi K., Sakoda T., Kishida S., Yamaguchi T., Wada K., Miyazaki M., and Takai Y. Rabphilin-3A, a putative target protein for smg p25A/rab3A p25 small GTP-binding protein related to synaptotagmin. Mol. Cell. Biol. 13 (1993) 2061-2068
32. Sons M.S., Busche N.S., Strenske N., Moser T., Ernsberger U., Mooren F.C., Zhang W., Ahmad M., Steffens H., Schomburg E.D., Plomp J.J., and Missler M. Alpha-neurexins are required for efficient transmitter release and synaptic homeostasis at the mouse neuromuscular junction. Neuroscience 138 (2006) 433-446
33. Star E.N., Newton A.J., and Murthy V.N. Real-time imaging of Rab3a and Rab5a reveals differential roles in presynaptic function. J. Physiol. 569 (2005) 103-117
34. Stevens C.F., and Tsujimoto T. Estimates for the pool size of releasable quanta at a single central synapse and for the time required to refill the pool. Proc. Natl. Acad. Sci. U. S. A. 92 (1995) 846-849
35. Sudhof T.C. The synaptic vesicle cycle. Annu. Rev. Neurosci. 27 (2004) 509-547
36. Sutton M.A., Wall N.R., Aakalu G.N., and Schuman E.M. Regulation of dendritic protein synthesis by miniature synaptic events. Science 304 (2004) 1979-1983
37. Ushkaryov Y.A., Volynski K.E., and Ashton A.C. The multiple actions of black widow spider toxins and their selective use in neurosecretion studies. Toxicon 43 (2004) 527-542
38. Varoqueaux F., Sigler A., Rhee J.S., Brose N., Enk C., Reim K., and Rosenmund C. Total arrest of spontaneous and evoked synaptic transmission but normal synaptogenesis in the absence of Munc13-mediated vesicle priming. Proc. Natl. Acad. Sci. U. S. A. 99 (2002) 9037-9042
39. Varoqueaux F., Sons M.S., Plomp J.J., and Brose N. Aberrant morphology and residual transmitter release at the Munc13-deficient mouse neuromuscular synapse. Mol. Cell. Biol. 25 (2005) 5973-5984
40. Verhage M., Maia A.S., Plomp J.J., Brussaard A.B., Heeroma J.H., Vermeer H., Toonen R.F., Hammer R.E., van den Berg T.K., Missler M., Geuze H.J., and Sudhof T.C. Synaptic assembly of the brain in the absence of neurotransmitter secretion. Science 287 (2000) 864-869
41. Wang Y., Sugita S., and Sudhof T.C. The RIM/NIM family of neuronal C2 domain proteins. Interactions with Rab3 and a new class of Src homology 3 domain proteins. J. Biol. Chem. 275 (2000) 20033-20044
42. Wood S.J., and Slater C.R. Safety factor at the neuromuscular junction. Prog. Neurobiol. 64 (2001) 393-429